Publications (59) Publications in which a researcher has participated View referenced research data.

filter_list Pharmacology

2023

  1. Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 67, Núm. 2

  2. Recommendations of the Spanish Antibiogram Committee (COESANT) for in vitro susceptibility testing of antimicrobial agents by disk diffusion

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 9, pp. 571-576

2022

  1. Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates

    Microbiology Spectrum, Vol. 10, Núm. 3

  2. Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence

    Microbiology Spectrum, Vol. 10, Núm. 1

2021

  1. 6-Halopyridylmethylidene Penicillin-Based Sulfones Efficiently Inactivate the Natural Resistance of Pseudomonas aeruginosa to β-Lactam Antibiotics

    Journal of Medicinal Chemistry, Vol. 64, Núm. 9, pp. 6310-6328

2020

  1. Clinically relevant epithelial lining fluid concentrations of meropenem with ciprofloxacin provide synergistic killing and resistance suppression of hypermutable pseudomonas aeruginosa in a dynamic biofilm model

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 7

  2. Predicting antimicrobial resistance in Pseudomonas aeruginosa with machine learning-enabled molecular diagnostics

    EMBO Molecular Medicine, Vol. 12, Núm. 3

2019

  1. Challenging antimicrobial susceptibility and evolution of resistance (oxa-681) during treatment of a long-term nosocomial infection caused by a pseudomonas aeruginosa ST175 Clone

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 10

  2. Four Decades of β-Lactam Antibiotic Pharmacokinetics in Cystic Fibrosis

    Clinical Pharmacokinetics, Vol. 58, Núm. 2, pp. 143-156

  3. In vitro and in vivo activities of -lactams in combination with the novel -lactam enhancers zidebactam and WCK 5153 against multidrug-resistant metallo-lactamase-producing klebsiella pneumoniae

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 5

  4. Regulation of AmpC-Driven β-Lactam Resistance in Pseudomonas aeruginosa: Different pathways, different signaling

    mSystems, Vol. 4, Núm. 6

  5. Synergistic meropenem-tobramycin combination dosage regimens against clinical hypermutable pseudomonas aeruginosa at simulated epithelial lining fluid concentrations in a dynamic biofilm model

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 11

  6. Therapeutic Efficacy of LN-1-255 in Combination with Imipenem in Severe Infection Caused by Carbapenem-Resistant Acinetobacter baumannii

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 10

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

  2. Ceftolozane/tazobactam for the treatment of multidrug resistant Pseudomonas aeruginosa: experience from the Balearic Islands

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 37, Núm. 11, pp. 2191-2200

  3. Deciphering β-lactamase-independent β-lactam resistance evolution trajectories in Pseudomonas aeruginosa

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 12, pp. 3322-3331

  4. Evaluation of ceftolozane-tazobactam in combination with meropenem against pseudomonas aeruginosa sequence type 175 in a hollow-fiber infection model

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 5

  5. Evolution of the Pseudomonas aeruginosa aminoglycoside mutational resistome in vitro and in the cystic fibrosis setting

    Antimicrobial Agents and Chemotherapy, Vol. 62, Núm. 4

  6. Identifying and exploiting genes that potentiate the evolution of antibiotic resistance

    Nature Ecology and Evolution, Vol. 2, Núm. 6, pp. 1033-1039

  7. Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu217-218 Insertion in the Ω-Loop

    Microbial Drug Resistance, Vol. 24, Núm. 5, pp. 527-533